Galapagos NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
13 mei 2013 - 17:40
Statutaire naam
Galapagos NV
Titel
Galapagos to present three posters on GLPG0634 at EULAR
Bericht
Mechelen, Belgium; 13 May 2013 - Galapagos NV (Euronext: GLPG) announced today that the Company will present three posters on selective JAK1 inhibitor GLPG0634 at the EULAR Annual European Congress of Rheumatology, which will take place from 12-15 June 2013 in Madrid, Spain. The abstracts are now available online at www.eular.org. Information going beyond that contained in the abstracts is under embargo until 00:01h of the opening day of the EULAR Congress, Wednesday 12 June.
Datum laatste update: 25 december 2025